EPA, DHA May Have Protective Effects in Pulmonary Fibrosis
Higher serum levels of the omega-3 fatty acids were associated with slowed disease progression and longer transplant-free survival in a new study.
Clinician Education on Obesity Has Not Caught Up to Disease State, Says OMA President
Angela Fitch, MD, discusses the importance of clinician education in addressing obesity with patients.
Addressing the Gap: Advocacy Groups Call for Inclusion of Patients with Obesity in Clinical Trials
President of the Obesity Medicine Association discusses a recent joint statement from the OMA and 4 other organizations calling for inclusion of patients with obesity in drug research.
Daily Dose: Impact of COVID-19 Pandemic on Parental Vaccine Hesitancy in the US
Your daily dose of the clinical news you may have missed.
Tips for Safe Post-Pandemic Telehealth Use
Beware the potential pitfalls of telemedicine, from privacy concerns to patient confusion, says associate general counsel for The Doctors Company.
Program Buoys Hope for Eradication of HCV
Is Technology the Answer to Revitalized Primary Care?
Health care leaders increasingly are looking to technology for solutions to the challenges facing primary care.
Daily Dose: USPSTF Recommends Behavioral Interventions for Children with Obesity
Migraine Management during the Holidays: How to Help Patients Identify, Manage Triggers
Common triggers, such as stress, travel, and disrupted routines, can impact patients with migraine this holiday season. Practical strategies and short-term preventive measures to help, here.
Knee Pain: Evaluation and Treatment of the Most Common Etiologies
Knee pain is the presenting symptom for ~5% of primary care visits. Following are highlight of a JAMA review covering the 3 most common etiologies.
Daily Dose: Pregnancy-related ESKD Influences Access to Nephrology Care
Daily Dose: Treating the Gut Microbiome Shortens Long COVID
New SARS-CoV-2 Variant Fastest Growing Strain in US: CDC
Infections with the JN.1 Omicron descendent have doubled since mid-November and now comprise 1 in 5 cases of COVID-19 in the US.
Key Developments in Obesity Medicine in 2023: An Expert Discussion
Angela Fitch, MD, president of the Obesity Medicine Association discusses key pharmaceutical and research developments in obesity medicine in 2023.
Daily Dose: Tirzepatide Discontinuation Results in Weight Regain
CDC: "Leverage All Available Tools" to Increase Flu, RSV, COVID Vaccination
Vaccination against all 3 cocirculating viruses are lower than this time last year and hospitalizations are up across age groups, according to a CDC Health Advisory.
FDA Grants Priority Review to Merck BLA for Investigational 21-Valent Pneumococcal Vaccine
If approved the 21-valent shot would be the first pneumococcal conjugate vaccine indicated specifically for adults.
Obesity Medicine Certificates Increase 40% from 2022 to 2023, says ABOM
The American Board of Obesity Medicine says annual first-time certificates now exceed those for cardiology, pulmonology, and medical oncology.
How Did the COVID-19 Pandemic Affect Parental Vaccine Hesitancy in the US?
Misinformation about COVID-19 vaccines may have eroded parents' trust in vaccination for their children, according to authors of new research.
FDA Updates LDL-C Lowering Indication for Bempedoic Acid, Bempedoic Acid plus Ezetimibe Tablets
The US FDA approved expanded indications for bempedoic acid and bempedoic acid plus ezetimibe for primary hyperlipidemia.